Teladoc Health, Inc. (NYSE:TDOC) Holdings Reduced by Alliancebernstein L.P.

Alliancebernstein L.P. reduced its holdings in Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 6.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 610,845 shares of the health services provider's stock after selling 44,583 shares during the quarter. Alliancebernstein L.P. owned approximately 0.35% of Teladoc Health worth $5,553,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in TDOC. Versant Capital Management Inc increased its holdings in shares of Teladoc Health by 313.8% during the 4th quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider's stock worth $29,000 after buying an additional 2,441 shares during the last quarter. Whipplewood Advisors LLC acquired a new stake in Teladoc Health during the fourth quarter worth about $29,000. Lindbrook Capital LLC increased its stake in Teladoc Health by 78.9% during the fourth quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock worth $33,000 after acquiring an additional 1,612 shares during the last quarter. Generali Investments Management Co LLC purchased a new position in shares of Teladoc Health in the 4th quarter worth about $64,000. Finally, PNC Financial Services Group Inc. lifted its stake in shares of Teladoc Health by 22.0% in the 4th quarter. PNC Financial Services Group Inc. now owns 7,978 shares of the health services provider's stock valued at $73,000 after purchasing an additional 1,439 shares in the last quarter. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Teladoc Health news, insider Adam C. Vandervoort sold 11,011 shares of the business's stock in a transaction on Thursday, March 20th. The shares were sold at an average price of $8.42, for a total transaction of $92,712.62. Following the completion of the sale, the insider now owns 64,308 shares in the company, valued at $541,473.36. The trade was a 14.62 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.95% of the stock is currently owned by company insiders.

Teladoc Health Stock Down 1.1 %

Shares of TDOC stock traded down $0.08 during mid-day trading on Friday, reaching $6.83. 3,830,334 shares of the company were exchanged, compared to its average volume of 6,244,597. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. The business's 50 day simple moving average is $9.17 and its 200 day simple moving average is $9.63. The company has a market capitalization of $1.20 billion, a P/E ratio of -1.18 and a beta of 1.73. Teladoc Health, Inc. has a fifty-two week low of $6.61 and a fifty-two week high of $15.21.

Teladoc Health (NYSE:TDOC - Get Free Report) last announced its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The company had revenue of $640.49 million for the quarter, compared to analyst estimates of $639.44 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. Research analysts predict that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

Wall Street Analyst Weigh In

TDOC has been the topic of several research reports. Piper Sandler cut their price target on shares of Teladoc Health from $13.00 to $12.00 and set an "overweight" rating on the stock in a report on Thursday, February 27th. The Goldman Sachs Group reduced their target price on shares of Teladoc Health from $16.00 to $13.00 and set a "buy" rating on the stock in a report on Monday, March 3rd. Oppenheimer decreased their price target on shares of Teladoc Health from $14.00 to $12.00 and set an "outperform" rating for the company in a research report on Friday, January 24th. Royal Bank of Canada raised their price objective on Teladoc Health from $11.00 to $12.00 and gave the company an "outperform" rating in a research report on Friday, January 24th. Finally, Bank of America decreased their target price on Teladoc Health from $9.50 to $8.00 and set a "neutral" rating for the company in a research report on Friday, April 11th. Eleven investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to data from MarketBeat.com, Teladoc Health presently has an average rating of "Hold" and a consensus price target of $10.94.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.